Medline Acquires Compat® Line of Pumps and Administration Sets in the U.S. and Canada MUNDELEIN, Ill.–(BUSINESS WIRE)–Medline Industries, Inc., a leading medical supply manufacturer and distributor, announces the acquisition of the Compat® line of pumps and administration sets in the U.S. and Canada from Nestlé Health Science. The Compat® pumps and sets deliver nutrition formulas or hydration to an enteral access device (feeding tube). The move establishes Medline as the second largest player in the enteral feeding pump and administration set market, thereby strengthening the company’s foothold and competitive position. om Nestlé Health Science read more
SpineGuard Obtains Regulatory Clearance to Sell PediGuard® in the World’s Second-Largest Spine Market: China
June 30, 2015 12:00 PM Eastern Daylight Time
PARIS & SAN FRANCISCO–(BUSINESS WIRE)–SpineGuard (FR0011464452 – ALSGD) announced today that it has received regulatory clearance to market its Classic PediGuard® products in China.
“This regulatory clearance is the result of a diligent collaborative process with General Care International (GCI)”
“This regulatory clearance is the result of a diligent collaborative process with General Care International (GCI),” said Pierre Jérôme, Co-founder and Chief Executive Officer of SpineGuard. “It is a major milestone for SpineGuard and further validates the value of our DSG™ (Dynamic Surgical Guidance)-based PediGuard device for making spine surgery safer.”
The China spine market has become the second-largest market in spine after the USA and is projected to be worth over $1 billion by 2019 according to IData Research, driven by an ageing population, increasing disease, improving treatment rate and growing affordability. “The number of spine fusions is growing rapidly across China, and I believe there is a strong need for a simple smart device like PediGuard consistently ensuring safe and accurate placement of pedicle screws,” added Professor Yong Qiu, Chief Spinal Surgeon at the Nanjing University Hospital.
LYCOS to Offer Purple Band & Ring to Support Epilepsy Awareness and New App Features LOS ANGELES–(BUSINESS WIRE)–LYCOS (NSE:LYCOS | BSE:532368) announced its latest initiative to increase Epilepsy awareness and support those living with Epilepsy. LYCOS is developing a new feature for the App for Life that will detect abnormal movements and alert loved ones when the user is experiencing these symptoms or has fallen. Lycos has introduced a purple band and ring with 20% of gross sales being shared to support the Epilepsy Foundation. tect Abnormal Movement
Quest Diagnostics and HealthTap Launch First Ever Virtual Diagnostic Testing for Healthcare Consumers
PALO ALTO, Calif. & MADISON, N.J.–(BUSINESS WIRE)–HealthTap, the world’s largest, most trusted digital health hub, providing 24/7 immediate access to personalized, high-quality information and virtual medical care from 71,000 U.S. doctors, and Quest Diagnostics (NYSE:DGX), the world’s leading provider of diagnostic information services, today announced a collaboration that will enable doctors to order diagnostic testing services for patients through HealthTap’s comprehensive virtual care platform. This is the first ever partnership between a major national medical laboratory provider and an end-to-end virtual care company, which will enable doctors and consumers to access a broad range of diagnostic service options to help care for patients in a virtual setting. read more